Recently, the landscape of weight management and metabolic health has been changed by a class of medications referred to as GLP-1 receptor agonists. In Germany, as in much of the developed world, the demand for these treatments– initially developed for Type 2 diabetes– has…[Read more]

Recently, the medical landscape for dealing with type 2 diabetes and weight problems has actually been transformed by a class of drugs referred to as GLP-1 receptor agonists (Glucagon-like peptide-1). In Germany, the need for these medications– most…[Read more]